Familial Chylomicronemia Syndrome (FCS) (HLP Type I)
1 clinical trials · Condition
◉ Watch Familial Chylomicronemia Syndrome (FCS) (HLP Type I)
| Record | Firm | Date |
|---|---|---|
| Extension to a Randomized, Double-blind, Placebo Controlled Study of LCQ908 in Subjects With Familial Chylomicronemia Syndrome. (NCT01589237) | Novartis Pharmaceuticals | 2013-02-01 |
Track Familial Chylomicronemia Syndrome (FCS) (HLP Type I) automatically
Every clearance here is in the API, with alerts when new ones post.